Target intelligence / Profile preview

Ring finger and CCCH-type domains 1 (RC3H1)

Target
RC3H1
Molecular classification
RNA-binding protein, E3 ubiquitin ligase, Zinc finger protein, Other
01

Overview

Ring finger and CCCH-type domains 1 (RC3H1), commonly known as Roquin-1, is a multifunctional RNA-binding protein and E3 ubiquitin ligase. It contains a RING finger domain (characteristic of E3 ubiquitin ligases), a ROQ domain, and a CCCH-type zinc finger domain, which allow it to recognize specific secondary RNA structures—mainly constitutive decay elements (CDEs)—in the 3′ untranslated regions (UTRs) of target mRNAs. RC3H1 mediates mRNA decay by recruiting deadenylase and decapping complexes (notably the CCR4-NOT complex), thus regulating post-transcriptional gene expression, particularly in immune-related transcripts like ICOS, OX40, A20, and TNFα. It thereby acts as a central regulator of immune homeostasis, inflammation, and T cell function. Mutations in RC3H1 are linked to severe immune dysregulation, including autoimmunity and hyperinflammatory syndromes. The protein is essential for limiting inappropriate T follicular helper cell activation and modulating signaling pathways such as NF-κB and the cellular DNA damage response[1][2][3][4][5][6][7].

Other names
Roquin-1KIAA2025RNF198RoquinRING finger and C3H zinc finger protein 1RING finger and CCCH-type zinc finger domain-containing protein 1RING finger protein 198FHL6IMDSHYprobable E3 ubiquitin-protein ligase RoquinRC3H1
02

Mechanism of action

Not applicable (no direct drugs, but theoretical mechanisms could involve inhibition or modulation of RNA/protein binding, E3 ligase activity, or enhancing/decreasing mRNA decay)

03

Biological functions

Post-transcriptional regulation of mRNA decayImmune responseRegulation of inflammationProtein ubiquitinationCell signalingDNA damage response
04

Disease associations

Autoimmune diseaseInflammationImmune dysregulation syndromesCancer (indirectly, via NF-κB and DNA damage pathways)
05

Safety considerations

Inhibition or loss of function may provoke severe immune activation, hyperinflammation, or autoimmunityDeletion causes lethal or severe immune phenotypes in mice
06

Interacting drugs

None established (no direct therapeutic drugs targeting RC3H1/Roquin-1 currently documented)
07

Biomarkers

Genetic mutation in RC3H1 may be diagnostic in rare immune dysregulation syndromesmRNA levels of RC3H1 or ICOS, TNF, A20 in immune monitoring

Beyond the preview

Go deeper on Ring finger and CCCH-type domains 1 (RC3H1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ring finger and CCCH-type domains 1 (RC3H1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call